AddLife AB (publ) appointed Fredrik Dalborg as president. Fredrik Dalborg succeeds Kristina Willg rd, previously announced decision to resign no later than during the fourth quarter of 2022, when Fredrik Dalborg is expected to take over. Fredrik Dalborg is very well-qualified and business-oriented leader with international experience deeply rooted in Life Science.

Fredrik leaves the listed company XVIVO Perfusion where Fredrik is part of the management team as managing director North America. Prior to that, Fredrik was president and CEO of Etac Group and listed Boule Diagnostics. In addition, Fredrik has held several senior positions in Life Science companies such as Terumo and Gambro.